ABI to Co-Develop Olink's PLA Technology to Enable Protein Quantitation on RT-PCR Platform | GenomeWeb
NEW YORK (GenomeWeb News) - Applied Biosystems said today that it will co-develop and commercialize Olink Bioscience's proximity ligation assay technology under an exclusive license.
 
ABI said the agreement gives it the right to commercialize the PLA technology for “specific applications” in the life science research market, including biomarker validation and characterization of biological processes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.